{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T11:13:15Z","timestamp":1772190795925,"version":"3.50.1"},"reference-count":22,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T00:00:00Z","timestamp":1398211200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0095881","type":"journal-article","created":{"date-parts":[[2014,4,23]],"date-time":"2014-04-23T18:39:09Z","timestamp":1398278349000},"page":"e95881","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Limited Utility of ITPA Deficiency to Predict Early Anemia in HCV Patients with Advanced Fibrosis Receiving Telaprevir"],"prefix":"10.1371","volume":"9","author":[{"given":"Alessio","family":"Aghemo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Grassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Grazia","family":"Rumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"D'Ambrosio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrico","family":"Galmozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabetta","family":"Degasperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Castaldi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberta","family":"Soffredini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massimo","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2014,4,23]]},"reference":[{"key":"ref1","first-page":"392","article-title":"EASL Clinical Practice Guidelines: management of hepatitis C virus infection","volume":"60(2)","year":"2014","journal-title":"J Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.dld.2012.05.002","article-title":"Directly acting antivirals for the treatment of chronic hepatitis C: unresolved topics from registration trials","volume":"45(1)","author":"A Aghemo","year":"2013","journal-title":"Dig Liver Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","article-title":"Triple therapy in treatment-experienced patients with HCV-cirrhosis in a multicentre cohort of the French Early Access Programme (ANRS CO20-CUPIC) - NCT01514890","volume":"59(3)","author":"C H\u00e9zode","year":"2013","journal-title":"J Hepatol"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Colombo M, Fern\u00e1ndez I, Abdurakhmano D, Ferreira PA, Strasser SI, <etal>et al<\/etal>.. (2013) Safety and on treatment efficacy of telaprevir: the early access program for patients with advanced hepatitis C. Gut DOI: 10.1136\/gutjnl-2013-305667.","DOI":"10.1136\/gutjnl-2013-305667"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Werner CR, Franz C, Egetemeyr DP, Malek NP, Laueret UM, <etal>et al<\/etal>.. (2013) Efficacy and safety of telaprevir (TVR) triple therapy in a \u2018real-life\u2019 cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment. J Viral Hepat DOI: 10.1111\/jvh.12145.","DOI":"10.1111\/jvh.12145"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"e55285","DOI":"10.1371\/journal.pone.0055285","article-title":"Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting","volume":"8(2)","author":"B Maasoumy","year":"2013","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1053\/j.gastro.2010.06.016","article-title":"Variants in the ITPA gene protect against ribavirin-induced hemolytic anemia and decrease the need for ribavirin dose reduction","volume":"139(4)","author":"AJ Thompson","year":"2010","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/jvh.12113","article-title":"Inosine triphosphatase deficiency helps predict anemia, anemia management and response in chronic hepatitis C therapy","volume":"20(12)","author":"PJ Clark","year":"2013","journal-title":"J Viral Hepat"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jhep.2013.05.017","article-title":"Clinical milestones for the prediction of severe anemia by chronic hepatitis C patients receiving telaprevir-based triple therapy","volume":"59(4)","author":"E Ogawa","year":"2013","journal-title":"J Hepatol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/hep.24058","article-title":"Influence of ITPA polymorphisms on decreases of hemoglobin during treatment with pegylated interferon, ribavirin, and telaprevir","volume":"53(2)","author":"F Suzuki","year":"2011","journal-title":"Hepatology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/hep.510240201","article-title":"An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group","volume":"24(2)","author":"P Bedossa","year":"1996","journal-title":"Hepatology"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ultrasmedbio.2003.07.001","article-title":"Transient elastography: a new noninvasive method for assessment of hepatic fibrosis","volume":"29(12)","author":"L Sandrin","year":"2003","journal-title":"Ultrasound Med Biol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1053\/j.gastro.2004.11.018","article-title":"Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C","volume":"128(2)","author":"L Cast\u00e9ra","year":"2005","journal-title":"Gastroenterology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.jviromet.2012.11.026","article-title":"Allelic inhibition of displacement activity: a simplified one tube allele-specific PCR for evaluation of ITPA polymorphisms","volume":"187(2)","author":"E Galmozzi","year":"2013","journal-title":"J Virol Methods"},{"key":"ref15","first-page":"26","article-title":"Increased plasma and intracellular ribavirin concentrations associated with telaprevir use","volume":"3","author":"K Hammond","year":"2013","journal-title":"Rev Antiv Ther Infect dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/jvh.12170","article-title":"Significant early higher ribavirin plasma concentrations in patients receiving a triple therapy with pegylated interferon, ribavirin and telaprevir","volume":"21(4)","author":"L Boglione","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/nature08825","article-title":"ITPA gene variants protect against anemia in patients treated for chronic hepatitis C","volume":"464(7287)","author":"J Fellay","year":"2010","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1053\/j.gastro.2010.12.038","article-title":"Inosine triphosphate protects against ribavirin-induced adenosine triphosphate loss by adenylosuccinate synthase function","volume":"40(4)","author":"Y Hitomi","year":"2011","journal-title":"Gastroenterology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"S459","DOI":"10.1016\/S0168-8278(12)61174-X","article-title":"Ribavirin dose modification in treatment-na\u00efve and previously treated patients who received telaprevir combination treatment: No impact on sustained virologic response in phase 3","volume":"56","author":"MS Sulkowski","year":"2011","journal-title":"J Hepatol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/j.jhep.2013.07.014","article-title":"Management of anemia induced by triple therapy in patients with chronic hepatitis C: challenges, opportunities and recommendations","volume":"59(6)","author":"M Romero-G\u00f3mez","year":"2013","journal-title":"J Hepatol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/hep.26096","article-title":"Anemia during treatment with peginterferon Alfa-2b\/ribavirin and boceprevir: Analysis from the serine protease inhibitor therapy 2 (SPRINT-2) trial","volume":"57(3)","author":"MS Sulkowski","year":"2013","journal-title":"Hepatology"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1053\/j.gastro.2013.07.051","article-title":"Effects of Ribavirin Dose Reduction vs Erythropoietin for Boceprevir-Related Anemia in Patients with Chronic HCV Genotype 1 Infection-a Randomized Trial","volume":"145(5)","author":"F Poordad","year":"2013","journal-title":"Gastroenterology"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0095881","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T20:33:16Z","timestamp":1540326796000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0095881"}},"subtitle":[],"editor":[{"given":"Yury E.","family":"Khudyakov","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2014,4,23]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2014,4,23]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0095881","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718361217.793494633","asserted-by":"object"}]},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,4,23]]}}}